PMDA drug package insert
ビリスコピン点滴静注50
PMDA Prescription drug · バイエル薬品株式会社 · package insert Jun 15, 2023
Key facts
| Brand names | ビリスコピン点滴静注50 |
|---|---|
| Nonproprietary names | イオトロクス酸メグルミン |
| Companies | 製造販売元／バイエル薬品株式会社 |
| Product type | Prescription drug |
| Therapeutic category | 点滴静注胆囊・胆管造影剤 |
| Therapeutic category codes | 877219 |
| YJ codes | 7219403A1038 |
| Approval numbers | 22100AMX00743000 |
| Package insert edition | 第2版 |
| Package insert date | Jun 15, 2023 |
| PMDA document key | 630004_7219403A1038_1 |
| PMDA company code | 630004 |
At a glance
- 1–9 Package insert revisions
- 1–9 Related PMDA documents
- None Safety communications
- No PMDA review report published
- No Risk management plan (RMP)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About PMDA approved drugs and package inserts (Japan)
Japan's PMDA publishes the package insert (添付文書) of every prescription drug, OTC drug and regenerative medical product, with brand and nonproprietary names, YJ codes and approval numbers. Names appear in Japanese as published.
Source: Pharmaceuticals and Medical Devices Agency (PMDA), Japan, package insert database · Source date: